• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL2000334 重组抗CD20人源化单克隆抗体皮下注射液 Recombinant anti-CD20 humanized monoclonal antibody Injection Biological Products(1) New Drug Application 2020-11-28 上海交联药物研发有限公司 Shanghai Shangyao Cross Linked Pharmaceutical Technology Co Ltd In Review 2020-11-27 view
CXSL1700072 注射用重组抗HER2人源化单克隆抗体-MCC-DM1偶联剂 B-003 Lyophilized Biological Products(2) New Drug Application 2017-07-31 上海交联药物研发有限公司 Shanghai Shangyao Cross Linked Pharmaceutical Technology Co Ltd Certificate Issued 2018-02-25 view